Connect your Claude, Codex or OpenClaw for full transcripts on millions of podcasts. Two week free trial, cancel anytime.
Start free trial →Prof G Markets · Money & Markets · October 2026
Ed Elson asked Eisman whether he would invest in Anthropic's IPO. Eisman said the bigger question than the S-1's numbers is whether the business has any moat at all; the 50% price cut he mentions is one he was treating as a report, not a confirmed fact.
No.
You got to the point quickly. I was going to ask you, would you need to know the answers to the questions that you just brought up before investing? I assume the answer is, yes, you would. Well,
yes, but I think, look, to me, the bigger, the bigger, bigger, bigger question is it just seems that there are no moats around this business. I mean, if it's the case that they actually did cut prices by 50%, that would reinforce the concept that there are no moats and that the only way you're going to gain share is price. Being in a business where you are committed to spend $800 billion where your entire franchise is just simply based on price is dangerous.
There is another interesting angle on this S1, which was the governance structure.
Oh, please. It's ridiculous. I mean, what's there to talk about? You're a shareholder in this company. You have no rights. Okay. Let's move on. If you want to invest in that company, that's up to you. You know, it's been disclosed. You have no rights, zero rights. You want to play? Play. You don't…
Just to clarify for our listeners, so there are multiple classes of stock here. You've got the regular voting shares. You've got the regular non-voting shares. Then you have this class T share, which is controlled by what they call the long-term benefit trust. And apparently, this is sort of this…